Exact Mass: 363.161654
Exact Mass Matches: 363.161654
Found 115 metabolites which its exact mass value is equals to given mass value 363.161654,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide
C16H21N5O5 (363.15426160000004)
Pglu-his-pro
C16H21N5O5 (363.15426160000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.
(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine
C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione
Cys Gly Gly Lys
C13H25N5O5S (363.15763200000004)
Cys Gly Lys Gly
C13H25N5O5S (363.15763200000004)
Cys Lys Gly Gly
C13H25N5O5S (363.15763200000004)
Gly Cys Gly Lys
C13H25N5O5S (363.15763200000004)
Gly Cys Lys Gly
C13H25N5O5S (363.15763200000004)
Gly Gly Cys Lys
C13H25N5O5S (363.15763200000004)
Gly Gly Lys Cys
C13H25N5O5S (363.15763200000004)
Gly Lys Cys Gly
C13H25N5O5S (363.15763200000004)
Gly Lys Gly Cys
C13H25N5O5S (363.15763200000004)
Lys Cys Gly Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Cys Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Gly Cys
C13H25N5O5S (363.15763200000004)
3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE
C21H22BNO4 (363.16418020000003)
(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride
C20H26ClNO3 (363.16011160000005)
(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester
Ozenoxacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine
C18H26BNO4S (363.1675506000001)
Protuboxepin B
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine
(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione
2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one
(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one
6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine
2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide
[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate
E1231
E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].
ZINC13466751
ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 μM[1].
2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one
methyl 4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
1-epidechloroacutumine
{"Ingredient_id": "HBIN002511","Ingredient_name": "1-epidechloroacutumine","Alias": "NA","Ingredient_formula": "C19H25NO6","Ingredient_Smile": "CN1CCC23C1(CCC24C(C(=CC4=O)OC)O)C(=C(C(=O)C3)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}